By 2020, it is estimated that 2.1 billion people will be presbyopic, and the demand for spectacle independence in this group is growing. This review article provides an overview of the three commercially available corneal inlays for the correction of presbyopia. Safety, efficacy, visual outcomes, and complications are analyzed for all three inlays according to published peer-reviewed data.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4298303 | PMC |
http://dx.doi.org/10.2147/OPTH.S57056 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!